Equity
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss
Medtronic AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss decreased by 2.1% to $47.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 62.4%, from $125.00M to $47.00M. Over 4 years (FY 2021 to FY 2025), AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss shows an upward trend with a 29.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ4 2018
Last reportedQ3 2026Feb 24, 2026
Metric ID:
afs_debt_securities_unrealized_loss_12m_plus_accHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32.00M | $29.00M | $49.00M | $79.00M | $244.00M | $267.00M | $456.00M | $331.00M | $297.00M | $317.00M | $337.00M | $219.00M | $238.00M | $162.00M | $128.00M | $125.00M | $91.00M | $75.00M | $48.00M | $47.00M |
| QoQ Change | — | -9.4% | +69.0% | +61.2% | +208.9% | +9.4% | +70.8% | -27.4% | -10.3% | +6.7% | +6.3% | -35.0% | +8.7% | -31.9% | -21.0% | -2.3% | -27.2% | -17.6% | -36.0% | -2.1% |
| YoY Change | — | — | — | — | +662.5% | +820.7% | +830.6% | +319.0% | +21.7% | +18.7% | -26.1% | -33.8% | -19.9% | -48.9% | -62.0% | -42.9% | -61.8% | -53.7% | -62.5% | -62.4% |
Range$29.00M – $456.00M
CAGR+8.4%
Avg YoY Growth+137.5%
Median YoY Growth-30.0%
Current Streak7 quarters decline
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) Accumulated Loss at Other Companies
Frequently Asked Questions
- What is Medtronic's afs and trading securities - unrealized loss position (>=12 months) accumulated loss?
- Medtronic (MDT) reported afs and trading securities - unrealized loss position (>=12 months) accumulated loss of $47.00M in Q4 2025.
- How has Medtronic's afs and trading securities - unrealized loss position (>=12 months) accumulated loss changed year-over-year?
- Medtronic's afs and trading securities - unrealized loss position (>=12 months) accumulated loss decreased by 62.4% year-over-year, from $125.00M to $47.00M.
- What is the long-term trend for Medtronic's afs and trading securities - unrealized loss position (>=12 months) accumulated loss?
- Over 4 years (2021 to 2025), Medtronic's afs and trading securities - unrealized loss position (>=12 months) accumulated loss has grown at a 29.9% compound annual growth rate (CAGR), from $32.00M to $91.00M.